180 related articles for article (PubMed ID: 6385611)
1. Oxandrolone in girls with Turner's syndrome. A pair-matched controlled study up to final height.
Joss E; Zuppinger K
Acta Paediatr Scand; 1984 Sep; 73(5):674-9. PubMed ID: 6385611
[TBL] [Abstract][Full Text] [Related]
2. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
3. Effect of oxandrolone on growth and final height in Turner's syndrome.
Naeraa RW; Nielsen J; Pedersen IL; Sørensen K
Acta Paediatr Scand; 1990; 79(8-9):784-9. PubMed ID: 2239273
[TBL] [Abstract][Full Text] [Related]
4. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
5. Oxandrolone increases final height in Turner syndrome.
Crock P; Werther GA; Wettenhall HN
J Paediatr Child Health; 1990 Aug; 26(4):221-4. PubMed ID: 2257185
[TBL] [Abstract][Full Text] [Related]
6. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
Gault EJ; Perry RJ; Cole TJ; Casey S; Paterson WF; Hindmarsh PC; Betts P; Dunger DB; Donaldson MD;
BMJ; 2011 Apr; 342():d1980. PubMed ID: 21493672
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
Rosenfeld RG
Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
[TBL] [Abstract][Full Text] [Related]
8. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
[TBL] [Abstract][Full Text] [Related]
9. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
10. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Turner's syndrome with recombinant human growth hormone (somatrem).
Lippe B; Rosenfeld RG; Hintz RL; Johanson AJ; Frane J; Sherman B
Acta Paediatr Scand Suppl; 1988; 343():47-52. PubMed ID: 3057808
[TBL] [Abstract][Full Text] [Related]
12. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
Bareille P; Massarano AA; Stanhope R
Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
[TBL] [Abstract][Full Text] [Related]
13. Anabolic steroids in girls with Turner's syndrome.
Joss EE
Acta Paediatr Scand Suppl; 1988; 343():38-42. PubMed ID: 3057807
[No Abstract] [Full Text] [Related]
14. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
15. Oxandrolone in constitutionally delayed growth, a longitudinal study up to final height.
Joss EE; Schmidt HA; Zuppinger KA
J Clin Endocrinol Metab; 1989 Dec; 69(6):1109-15. PubMed ID: 2584350
[TBL] [Abstract][Full Text] [Related]
16. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
Stahnke N; Keller E; Landy H;
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Haeusler G; Frisch H
Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
[TBL] [Abstract][Full Text] [Related]
19. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.
Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G
J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706
[TBL] [Abstract][Full Text] [Related]
20. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
Price DA; Albertsson-Wikland K
Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():69-74. PubMed ID: 8219480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
